ArticleFrontiers in oncology2026

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications.

İlkay Çıtakkul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.